Clinical Trials Logo

Clinical Trial Summary

Patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents risk to develop muscle weakness associated with prolonged period of mechanical ventilation support and hospital stay.


Clinical Trial Description

Intensive care unit (ICU) acquired muscle weakness affects both respiratory and peripheral muscles and can contribute to worsen clinical and functional outcomes. In this way, ultrasonography muscle evaluation could help to identify early alterations guiding the therapeutic planning and allowing to monitor the interventions performed. Therefore, the investigators intend to follow up mechanically ventilated patients with confirmed diagnosis of COVID-19 during ICU stay to quantify the diaphragm, parasternal intercostal, abdominals and femoral quadriceps muscles thickness assessed by ultrasonography. Additionally, functional capacity, frailty and level of physical activity will be evaluated and followed for pre-admission condition and 30, 90 and 180 days after hospital discharge . ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05063214
Study type Observational [Patient Registry]
Source Hospital Israelita Albert Einstein
Contact Ricardo K Nawa, PT MSc PhD
Phone +55 11 2151-0603
Email [email protected]
Status Recruiting
Phase
Start date September 30, 2021
Completion date September 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05077969 - Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2) Phase 2
Not yet recruiting NCT05077332 - LEAP-CT for Treatment of COVID-19 Patients (Master Protocol) Phase 2
Not yet recruiting NCT05013034 - Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients Phase 2
Completed NCT04998253 - Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2 Early Phase 1
Not yet recruiting NCT05074121 - NAC for Attenuation of COVID Symptomatology Phase 2
Recruiting NCT04929691 - The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Among Patients With COVID-19 N/A
Recruiting NCT04894682 - Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor
Recruiting NCT05042193 - A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19
Recruiting NCT04896866 - Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP) N/A
Active, not recruiting NCT05008562 - HOW SARS COV- 2 EFFECTS TO MUSCLE MASS CHANGE IN ICU?
Recruiting NCT04954157 - Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients N/A
Not yet recruiting NCT04913142 - About Oral and Gut Microbiota in Intensive Care Unit : SARS-CoV-2 (COVID-19) Infection Impact.
Not yet recruiting NCT04944381 - Study of Ameliorating Effect of COVID-19 mRNA Vaccine in Individuals Immunized With Inactivated Vaccine N/A
Recruiting NCT04681430 - Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals Phase 2
Recruiting NCT04949230 - A Retrospective Study of COVID-19 Treatments
Recruiting NCT05004181 - Safety and Immunogenicity of a SARS CoV 2 Multivalent RNA Vaccine in Healthy Participants Phase 2
Not yet recruiting NCT04969614 - Safety and Immunogenicity of 2-dose Inactivated COVID-19 Vaccine in Kidney Transplant Recipients
Completed NCT04880122 - Dried Blood Spots for SARS-CoV-2 Serology (COVID-19). N/A
Recruiting NCT05042232 - A Prospective Virtual Study of Patient Reported Behaviors and Health Outcomes in Individuals With COVID-19